Fate Therapeutics Files Prospectus For Offering $300M Mixed Shelf
https://www.sec.gov/Archives/edgar/data/1434316/000119312526450034/d150438ds3.htm
Share
Why It Matters
Fate Therapeutics is preparing to raise up to $300 million by selling new shares or debt. When a company does this, watch whether they need cash fast or are planning ahead.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.